MedTrace Logo

The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers

NCT00805870 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-09-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effects of fish oil supplementation (Lovaza, GlaxoSmithKline) on muscle strength, muscle soreness and inflammation following exercise.

Conditions

  • Muscle Damage
  • Muscle Inflammation

Interventions

DRUG

Lovaza (omega-3-acid ethyl esters)

Lovaza, 3 grams per day for 65 days

DRUG

Wheat Germ Oil

Wheat germ oil, 3 grams/day for 65 days

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Western Michigan University

    lead OTHER

Principal Investigators

  • Christopher C Cheatham, Ph.D. · Western Michigan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-12-31
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00805870 on ClinicalTrials.gov